AlgaVac which aims to shape the future of vaccination in the field of aquaculture with its disruptive microalgae-based oral delivery technology have two exclusive business development collaboration agreement with Virbac, a French company and one of the leading animal health players worldwide. The companies develop together two oral fish vaccines based on AlgaVac’s break-through technology and are engaged together in a long term business relationship.